Proteomics analyses have also indicated that the administration of curcumin at doses ranging from 25 μM or 1737 μM over a period of 72 h can reverse multi-drug resistance in tumors and inhibit tumor cell proliferation by reducing the PRDX6 levels through p53 [77,78]. The gene discussed is PRDX6; the disease is neoplasm.